Increasing LAG-3 expression suppresses T-cell function in chronic hepatitis B

Abstract Weak or absent virus-specific CD8+ T-cell responses to hepatitis B virus (HBV) infection are thought to be responsible for persistent HBV infection. Previous studies have indicated that multiple inhibitory receptors, including lymphocyte activation gene-3 (LAG-3), can suppress the CD8+ T-cell response in chronic viral infection. This study aimed to detect LAG-3 expression and to investigate the manner in which the immune response is regulated to balance the strength of the response with the extent of liver injury in chronic HBV infection. The results showed that LAG-3 expression levels were significantly higher in CD8+ T cells from chronic hepatitis B patients in the immune-active phase compared with chronic asymptomatic HBV carriers and healthy controls. CD8+ T-cell function was suppressed in cells with high LAG-3 expression, and these cells exhibited reduced interferon-&ggr; (IFN-&ggr;) secretion. Furthermore, IFN-&ggr; secretion was restored in CD8+ T cells that were treated with a specific antibody to LAG-3. Taken together, liver injury was prominent in the immune-active phase, but suppressing T-cell function could mitigate this damage. Importantly, the inhibitory function of LAG-3 can be blocked using a LAG-3-specific antibody, and this can restore the activity of non-functional T cells.

[1]  Cindy J. Lai.  Medicine (MEDICINE) , 2017 .

[2]  L. Yao,et al.  Expression of LAG-3 is coincident with the impaired effector function of HBV-specific CD8(+) T cell in HCC patients. , 2013, Immunology letters.

[3]  Chatchawan Wongjitrat,et al.  CTLA-4 and its ligands on the surface of T- and B-lymphocyte subsets in chronic hepatitis B virus infection. , 2013, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[4]  Peter Vogel,et al.  Microenvironment and Immunology Immune Inhibitory Molecules Lag-3 and Pd-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune Escape , 2022 .

[5]  E John Wherry,et al.  T cell exhaustion , 2011 .

[6]  J. Haas,et al.  The immunoregulatory role of CD244 in chronic hepatitis B infection and its inhibitory potential on virus‐specific CD8+ T‐cell function , 2010, Hepatology.

[7]  Lloyd J. Old,et al.  Tumor-infiltrating NY-ESO-1–specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer , 2010, Proceedings of the National Academy of Sciences.

[8]  A. Oxenius,et al.  How chronic viral infections impact on antigen‐specific T‐cell responses , 2010, European journal of immunology.

[9]  A. Oxenius,et al.  On the role of the inhibitory receptor LAG-3 in acute and chronic LCMV infection. , 2010, International immunology.

[10]  E. Wherry,et al.  A role for the transcriptional repressor Blimp-1 in CD8(+) T cell exhaustion during chronic viral infection. , 2009, Immunity.

[11]  D. Getnet,et al.  Functionally Distinct LAG-3 and PD-1 Subsets on Activated and Chronically Stimulated CD8 T Cells1 , 2009, The Journal of Immunology.

[12]  E. Wherry,et al.  The diversity of costimulatory and inhibitory receptor pathways and the regulation of antiviral T cell responses. , 2009, Current opinion in immunology.

[13]  C. Drake,et al.  LAG-3 Regulates Plasmacytoid Dendritic Cell Homeostasis1 , 2009, The Journal of Immunology.

[14]  Antonio Polley,et al.  Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection , 2009, Nature Immunology.

[15]  S. Chokshi,et al.  Programmed death 1 expression during antiviral treatment of chronic hepatitis B: Impact of hepatitis B e‐antigen seroconversion , 2008, Hepatology.

[16]  D. Getnet,et al.  LAG-3 regulates CD8+ T cell accumulation and effector function in murine self- and tumor-tolerance systems. , 2007, The Journal of clinical investigation.

[17]  C. Blobel,et al.  Metalloproteases regulate T‐cell proliferation and effector function via LAG‐3 , 2007, The EMBO journal.

[18]  F. von Weizsäcker,et al.  Pathogenesis of hepatitis B virus infection. , 2007, World journal of gastroenterology.

[19]  F. Triebel,et al.  The negative regulatory function of the lymphocyte‐activation gene‐3 co‐receptor (CD223) on human T cells , 2005, Immunology.

[20]  D. Vignali,et al.  Negative Regulation of T Cell Homeostasis by Lymphocyte Activation Gene-3 (CD223)1 , 2005, The Journal of Immunology.

[21]  In-Jeong Kim,et al.  Lymphocyte Activation Gene-3 (CD223) Regulates the Size of the Expanding T Cell Population Following Antigen Activation In Vivo1 , 2004, The Journal of Immunology.

[22]  F. Triebel.  LAG-3: a regulator of T-cell and DC responses and its use in therapeutic vaccination. , 2003, Trends in immunology.

[23]  S. Litwin,et al.  INAUGURAL ARTICLES: Hepatocyte turnover during resolution of a transient hepadnaviral infection , 2003 .

[24]  R. Purcell,et al.  CD8+ T Cells Mediate Viral Clearance and Disease Pathogenesis during Acute Hepatitis B Virus Infection , 2003, Journal of Virology.

[25]  T. JaimePoniachik,et al.  Fulminant hepatic failure , 2002 .

[26]  N. Burdin,et al.  Maturation and Activation of Dendritic Cells Induced by Lymphocyte Activation Gene-3 (CD223)1 , 2002, The Journal of Immunology.

[27]  Ding‐Shinn Chen,et al.  Hepatitis B Virus Infection , 2007 .